chr21-46003802-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_001848.3(COL6A1):āc.2876T>Cā(p.Val959Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000951 in 1,608,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001848.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A1 | NM_001848.3 | c.2876T>C | p.Val959Ala | missense_variant | Exon 35 of 35 | ENST00000361866.8 | NP_001839.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152158Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000182 AC: 45AN: 247208Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134508
GnomAD4 exome AF: 0.0000563 AC: 82AN: 1456506Hom.: 0 Cov.: 34 AF XY: 0.0000539 AC XY: 39AN XY: 723670
GnomAD4 genome AF: 0.000466 AC: 71AN: 152276Hom.: 0 Cov.: 34 AF XY: 0.000403 AC XY: 30AN XY: 74462
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
Identified in a patient with limb girdle muscular dystrophy (Nallamilli et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30564623) -
- -
Bethlem myopathy 1A Uncertain:1Benign:1
- -
- -
not specified Benign:1
Variant summary: COL6A1 c.2876T>C (p.Val959Ala) results in a non-conservative amino acid change located in the Overlapping homologous superfamilies domain (IPR002035) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00018 in 247208 control chromosomes, predominantly at a frequency of 0.0022 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 4631 fold of the estimated maximal expected allele frequency for a pathogenic variant in COL6A1 causing Collagen Type VI-Related Disorders phenotype (4.8e-07), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.2876T>C has been reported in the literature in at-least one individual reported with a clinical suspicion for LGMD, however authors classified the variant as VUS (Nallamilli_2018). This report does not provide unequivocal conclusions about association of the variant with Collagen Type VI-Related Disorders. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as VUS (n=2) and likely benign (n=1). Based on the evidence outlined above, the variant was classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at